Human whole blood granulocytes were stained with Mouse Anti-Human TRAIL R4/TNFRSF10D Alexa Fluor® 488-conjugated Monoclonal Antibody (Catalog # FAB633G, filled histogram) or isotype control antibody (Catalog # ...read more
Mouse myeloma cell line NS0-derived recombinant human TRAIL R4/TNFRSF10D Ala56-His211 Accession # Q9UBN6
Specificity
Detects human TRAIL R4/TNFRSF10D in ELISAs and Western blots. In sandwich immunoassays, less than 5% cross-reactivity with recombinant human (rh) TRAIL R1, rhTRAIL R2, rhTRAIL R3, rhTRAIL, rhTNF‑ alpha , and rhTNF-beta is observed.
Source
N/A
Isotype
IgG1
Clonality
Monoclonal
Host
Mouse
Gene
TNFRSF10D
Purity Statement
Protein A or G purified from ascites
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
Store the unopened product at 2 - 8° C. Do not use past expiration date. Protect from light.
Buffer
Supplied in a saline solution containing BSA and Sodium Azide.
Preservative
Sodium Azide
Notes
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for TRAILR4/TNFRSF10D/DcR2 Antibody (104918) [Alexa Fluor® 488]
CD264 antigen
CD264
DcR2
DCR2decoy with truncated death domain
Decoy receptor 2
TNF receptor-related receptor for TRAIL
TNF-related apoptosis-inducing ligand receptor 4
TNFRSF10D
TRAIL R4
TRAILR4
TRAIL-R4
TRAILR4TRAIL receptor 4
TRUNDDTRAIL receptor with a truncated death domain
tumor necrosis factor receptor superfamily member 10D
tumor necrosis factor receptor superfamily, member 10d, decoy with truncateddeath domain
Background
TRAIL-R4, also known as TRAIL-R4 alpha , Decoy Receptor 2 (DcR2) and TNFRSF10D,
is a 39-48 kDa member of the TNFR Superfamily of proteins. Mature TRAIL-R4/DcR2 is a type I
transmembrane protein 331 amino acids (aa) in length. It contains a 156 aa extracellular domain
(ECD) (aa 56-211), and a 154 aa cytoplasmic region that contains a truncated
death domain. The presence of this
truncation is not believed to allow for a positive signal for the initiation of
apoptosis. This has led to its description
as a "decoy receptor", suggesting that its function is to simply sequester and decrease
the amount of TRAIL available for binding to the two apoptosis-inducing TRAIL
receptors, DR4 and DR5. At this time,
this view would appear to be unlikely, as it now seems that DcR2 actually
complexes with DR5/TRAIL-R2, blocking the activation of Caspase-8, a first step
in the initiation of apoptosis. In
addition, in a ligand-dependent manner, the presence of DcR2 has also been
associated with the increased survival of select leukocytes. Notably, an isoform variant for TRAIL-R4
(called TRAIL-R4 beta ) has been reported that shows an absence of aa 87-124, a
deletion that would render it incapable of binding to TRAIL. Cells reported to express TRAIL-R4 are
varied, and include eosinophils, NKT cells, CD8+ (but not CD4+) T cells, colonic
columnar epithelium, neutrophils, endometrial columnar epithelium, testicular
spermatids and testosterone-secreting Leydig cells, and multiple tumor cell
types. A rodent counterpart to TRAIL-R4
has not been reported.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for TRAILR4/TNFRSF10D/DcR2 Antibody (FAB633G) (0)
There are no reviews for TRAILR4/TNFRSF10D/DcR2 Antibody (FAB633G).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our TRAILR4/TNFRSF10D/DcR2 Antibody (104918) [Alexa Fluor® 488] and receive a gift card or discount.